Audience
What’s on for Therapeutic Developers:
- Panel: Why Europe for ATMPS? Collaboration, Diversification and Leading the Charge for Cell and Gene Therapies
- Debate: Facilitating Equity & Access for Global Cell and Gene Therapy Patients: How Do We Get There From Here
- Session: Optimising Business Models for Emerging Biotech
- Session: Transforming the ATMP Value Chain: The Power of Digitalisation in Cell and Gene Therapy
- Session: Accelerating Cell and Gene Therapy Innovation: Regulatory Pathways in Europe
What’s on for Academics & Healthcare:
- Track: Developing ATMPs Track
- Exhibition: Innovation Zone
- Debate: Facilitating Equity & Access for Global Cell and Gene Therapy Patients: How Do We Get There From Here
- Session: Ensuring Speed, Safety, and Supply in Delivering Therapies to Patients
- Session: Accelerating Cell and Gene Therapy Innovation: Regulatory Pathways in Europe
What’s on for Start-ups:
- Exhibition: Innovation Zone
- Track: Commercialising Future Therapies
- Session: Optimising Business Models for Emerging Biotech
What’s on for Manufacturers:
- Track: Commercialising Future Therapies Track
- Track: Technical Excellence Track
- Session: Scaling Up: Manufacturing Strategies for Commercial Success in Cell and Gene Therapy
- Session: Building Essential Manufacturing Competencies for ATMPs from the Outset